About Us Contact Us Sitemap

Cell and Gene Therapy Thawing Equipment Market, By Product Type (Automated Thawing Systems, Manual Thawing Devices, Water-Free / Dry Thawing Systems, and Accessories & Consumables), By Workflow Stage, By Therapy Type, By Modality, By End User, By Distribution Channel, By Country, and By Region Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033

Market Research Image
Report ID AV5561
Published Date July 2026
Pages 381
Industry Healthcare
Format PPT/PDF
Base Year 2025
Historical Data 2019-2024
Delivery Timeline 24 Hour

REPORT HIGHLIGHT

Cell and Gene Therapy Thawing Equipment Market size was valued at US$ 1,205.6 Million in 2025, expanding at a CAGR of 13.8% from 2026 to 2033.

The Cell and Gene Therapy Thawing Equipment market is gaining increasing importance due to the rising adoption of cell and gene therapies for the treatment of cancer, rare genetic disorders, and other complex diseases. These advanced therapies are typically cryopreserved to maintain cellular stability, biological activity, and therapeutic effectiveness during storage and transportation. As a result, the thawing process has become a critical stage in the therapy lifecycle, as improper temperature control or handling can negatively impact cell viability, product quality, and treatment outcomes.

With more cell and gene therapies progressing from clinical development toward commercial-scale manufacturing, biopharmaceutical companies are focusing on advanced thawing technologies to improve process consistency, regulatory compliance, scalability, and product traceability. According to the U.S. Food and Drug Administration (FDA), the number of approved cell and gene therapy products has continued to increase, with the agency expecting a significant rise in applications and approvals of advanced therapies in the coming years. This growing regulatory momentum and expansion of the cell and gene therapy pipeline are driving demand for reliable thawing equipment that can support safe, efficient, and large-scale therapeutic production.

Cell and Gene Therapy Thawing Equipment Market- Market Dynamics

Advancing Healthcare Through Transparent Decision-Making

Market growth is being driven by the significant advantages that automated thawing technologies bring to cell and gene therapy workflows, particularly improved clinical outcomes and enhanced regulatory compliance. In addition, remote monitoring systems increase operational transparency by enabling real-time oversight and data capture across multiple sites. Early adopters have reported improved cell viability, shorter processing times, and simplified regulatory compliance. As a result, automation is no longer viewed solely as a means of improving operational efficiency; it also contributes to more consistent manufacturing processes and better, more predictable patient outcomes. At the same time, the industry is increasingly adopting systems that generate comprehensive, auditable records to support Good Manufacturing Practice (GMP) compliance.

Automated, closed-system thawing devices play a critical role in meeting GMP requirements by minimizing contamination risks while ensuring the safety, consistency, and viability of cell therapy products during both clinical and commercial manufacturing. For example, Cytiva\'s VIA Thaw™ series provides controlled thawing within a closed environment, enabling a standardized and fully traceable thawing process suitable for GMP-compliant workflows. Consequently, the market is shifting away from manual thawing methods toward hybrid and fully automated platforms that deliver consistent thawing cycles with minimal human intervention, improving both process reliability and product quality.

Cell and Gene Therapy Thawing Equipment Market- Segmentation Analysis:
The Global Cell and Gene Therapy Thawing Equipment Market is segmented on the basis of Product Type, Workflow Stage, Therapy Type, Modality, End User, Distribution Channel, and Region.

The product type segment is dominated by automated thawing systems, driven by their reliability, scalability, and compliance with Good Manufacturing Practices (GMP). Among these, water-free thawing systems represent the fastest-growing sub-segment, as they eliminate the contamination risks associated with traditional water-bath methods. Industry reports indicate that the water-free thawing systems segment is expected to generate the highest revenue over the forecast period. In contrast, manual thawing devices continue to maintain a meaningful share, particularly in research settings, due to their lower cost. However, their market share is gradually declining as commercial manufacturers increasingly adopt validated and automated thawing solutions. Accessories and consumables, including thaw bags, vials, and single-use components, constitute a smaller but recurring revenue segment, with demand increasing in line with the growing volume of cell and gene therapy procedures.

Within the workflow stage segmentation, the clinical use segment currently accounts for the largest market share, reflecting the fact that a significant proportion of approved and pipeline cell and gene therapies remain in the clinical development phase. According to the Alliance for Regenerative Medicine, more than 2,000 regenerative medicine and advanced therapy clinical trials are currently underway worldwide, underscoring the substantial volume of products progressing through clinical development. Looking ahead, the commercial manufacturing segment is expected to witness the fastest growth as more therapies receive regulatory approval and transition to large-scale production. Within this stage, the adoption pattern of manual versus automated thawing systems mirrors the broader product-type trend, with automated solutions gaining increasing preference due to their ability to deliver standardized, scalable, and regulatory-compliant thawing processes.

Cell and Gene Therapy Thawing Equipment Market- Geographical Insights

North America currently leads the cell and gene therapy thawing equipment market, driven by its well-established biopharmaceutical industry and the strong presence of major cell and gene therapy developers, manufacturers, and contract development and manufacturing organizations (CDMOs). In 2024, the region accounted for the largest share of the global market, supported by advanced biopharmaceutical infrastructure, continued innovation in regenerative medicine, and widespread adoption of thawing equipment across both clinical trial sites and commercial manufacturing facilities, particularly in the United States. Industry reports consistently indicate that North America generated the highest share of global revenue in 2024, reinforcing its position as the leading hub for clinical development and large-scale cell and gene therapy manufacturing.

Asia-Pacific is expected to be the fastest-growing regional market during the forecast period. This growth is primarily driven by increasing investments in biotechnology, expanding clinical research activities, and supportive government initiatives promoting the development of advanced therapies in countries such as China, Japan, and South Korea. In addition, the rapid expansion of biopharmaceutical manufacturing capabilities, growing healthcare investments, and rising adoption of cell and gene therapies are expected to accelerate demand for thawing equipment across the region, positioning Asia-Pacific as a key growth market in the coming years.

Cell and Gene Therapy Thawing Equipment Market- Competitive Landscape:

The competitive landscape of the cell and gene therapy thawing equipment market is characterized by a combination of established life sciences instrumentation companies and specialized cryopreservation technology providers. Strategic acquisitions have emerged as the primary growth strategy, enabling companies to strengthen their cell and gene therapy (CGT) portfolios and expand end-to-end workflow capabilities. Cytiva is a key market participant, driven by its VIA Thaw product portfolio, which provides controlled, water-free thawing designed to support Good Manufacturing Practice (GMP)-compliant workflows. GE HealthCare has also strengthened its position through the acquisition of Asymptote, enhancing its capabilities in cryopreservation and thawing technologies to support broader adoption of cell therapies and improve workflow solutions for customers. However, the VIA Thaw CB1000 system is intended for research and clinical applications and is not currently designed for commercial-scale manufacturing.

BioLife Solutions differentiates itself through its evo Thaw system, which offers precise temperature control to improve consistency and cell viability during thawing. Meanwhile, companies such as Sartorius, Merck KGaA, and PHC Holdings continue to focus primarily on their broader cold-chain management, cryogenic storage, and biostorage portfolios, with comparatively limited recent developments in dedicated thawing technologies. Overall, the competitive environment indicates that leading cold-chain and life sciences companies are increasingly relying on acquisitions of specialized thawing technology providers rather than in-house product development to strengthen their CGT offerings.

Recent Developments

  • In April 2024, BioLife Solutions expanded its biopreservation portfolio by integrating cryogenic storage, cold-chain logistics, and thawing workflow capabilities, further strengthening its support for commercial cell and gene therapy manufacturing.

  • GE HealthCare has continued to leverage its acquisition of Asymptote to enhance its cryopreservation and thawing technology portfolio, supporting the growing demand for integrated cell therapy manufacturing solutions.

SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Thermo Fisher Scientific
  • Azenta Life Sciences
  • Barkey GmbH & Co. KG
  • Cardinal Health
  • Cytiva
  • BioLife Solutions
  • Sartorius
  • Merck KGaA
  • PHC Holdings Corporation
  • Eppendorf
  • Helmer Scientific
  • B Medical Systems
  • Azenta Life Sciences
  • Cytiva
  • MedCision
  • Haier Biomedical
  • Others

GLOBAL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2020 - 2033

  • Automated Thawing Systems
  • Manual Thawing Devices
  • Water-Free / Dry Thawing Systems
  • Accessories & Consumables

GLOBAL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY WORKFLOW STAGE- MARKET ANALYSIS, 2020 - 2033

  • Research & Preclinical Applications
  • Clinical Use
  • Commercial Manufacturing

GLOBAL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY THERAPY TYPE- MARKET ANALYSIS, 2020 - 2033

  • Cell Therapy
  • Gene Therapy
  • Gene-Modified Cell Therapy

GLOBAL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY MODALITY- MARKET ANALYSIS, 2020 - 2033

  • Benchtop
  • Portable

GLOBAL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY END USER- MARKET ANALYSIS, 2020 - 2033

  • Biopharmaceutical & Biotechnology Companies
  • Contract Development & Manufacturing Organizations (CDMOs)
  • Academic & Research Institutes
  • Hospitals & Clinical Centers
  • Cord Blood and Stem Cell Banks
  • Gene Banks

GLOBAL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL- MARKET ANALYSIS, 2020 - 2033

  • Direct Tender
  • Third Party Distributor

GLOBAL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033

North America

  • U.S.
  • Canada

Europe

  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe

Asia Pacific

  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM

The Middle East and Africa

  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

TABLE OF CONTENT

1. Cell and Gene Therapy Thawing Equipment Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Cell and Gene Therapy Thawing Equipment Market Snippet by Product Type
2.1.2. Cell and Gene Therapy Thawing Equipment Market Snippet by Workflow Stage
2.1.3. Cell and Gene Therapy Thawing Equipment Market Snippet by Therapy Type
2.1.4. Cell and Gene Therapy Thawing Equipment Market Snippet by Modality
2.1.5. Cell and Gene Therapy Thawing Equipment Market Snippet by End User
2.1.6. Cell and Gene Therapy Thawing Equipment Market Snippet by Distribution Channel
2.1.7. Cell and Gene Therapy Thawing Equipment Market Snippet by Country
2.1.8. Cell and Gene Therapy Thawing Equipment Market Snippet by Region
2.2. Competitive Insights
3. Cell and Gene Therapy Thawing Equipment Key Market Trends
3.1. Cell and Gene Therapy Thawing Equipment Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Cell and Gene Therapy Thawing Equipment Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Cell and Gene Therapy Thawing Equipment Market Opportunities
3.4. Cell and Gene Therapy Thawing Equipment Market Future Trends
4. Cell and Gene Therapy Thawing Equipment Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Cell and Gene Therapy Thawing Equipment Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Cell and Gene Therapy Thawing Equipment Market Landscape
6.1. Cell and Gene Therapy Thawing Equipment Market Share Analysis, 2025
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Cell and Gene Therapy Thawing Equipment Market – By Product Type
7.1. Overview
7.1.1. Segment Share Analysis, By Product Type, 2025 & 2033 (%)
7.1.2. Automated Thawing Systems
7.1.3. Manual Thawing Devices
7.1.4. Water-Free / Dry Thawing Systems
7.1.5. Accessories & Consumables
8. Cell and Gene Therapy Thawing Equipment Market – By Workflow Stage
8.1. Overview
8.1.1. Segment Share Analysis, By Workflow Stage, 2025 & 2033 (%)
8.1.2. Research & Preclinical Applications
8.1.3. Clinical Use
8.1.4. Commercial Manufacturing
9. Cell and Gene Therapy Thawing Equipment Market – By Therapy Type
9.1. Overview
9.1.1. Segment Share Analysis, By Therapy Type, 2025 & 2033 (%)
9.1.2. Cell Therapy
9.1.3. Gene Therapy
9.1.4. Gene-Modified Cell Therapy
10. Cell and Gene Therapy Thawing Equipment Market – By Modality
10.1. Overview
10.1.1. Segment Share Analysis, By Modality, 2025 & 2033 (%)
10.1.2. Benchtop
10.1.3. Portable
11. Cell and Gene Therapy Thawing Equipment Market – By End User
11.1. Overview
11.1.1. Segment Share Analysis, By End User, 2025 & 2033 (%)
11.1.2. Biopharmaceutical & Biotechnology Companies
11.1.3. Contract Development & Manufacturing Organizations (CDMOs)
11.1.4. Academic & Research Institutes
11.1.5. Hospitals & Clinical Centers
11.1.6. Cord Blood and Stem Cell Banks
11.1.7. Gene Banks
12. Cell and Gene Therapy Thawing Equipment Market – By Distribution Channel
12.1. Overview
12.1.1. Segment Share Analysis, By Distribution Channel, 2025 & 2033 (%)
12.1.2. Direct Tender
12.1.3. Third Party Distributor
13. Cell and Gene Therapy Thawing Equipment Market– By Geography
13.1. Introduction
13.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
13.2. North America
13.2.1. Overview
13.2.2. Cell and Gene Therapy Thawing Equipment Key Manufacturers in North America
13.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
13.2.4. North America Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
13.2.5. North America Market Size and Forecast, By Workflow Stage, 2020 - 2033 (US$ Million)
13.2.6. North America Market Size and Forecast, By Therapy Type, 2020 - 2033 (US$ Million)
13.2.7. North America Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
13.2.8. North America Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
13.2.9. North America Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
13.2.10. U.S.
13.2.10.1. Overview
13.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
13.2.10.3. U.S. Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
13.2.10.4. U.S. Market Size and Forecast, By Workflow Stage, 2020 - 2033 (US$ Million)
13.2.10.5. U.S. Market Size and Forecast, By Therapy Type, 2020 - 2033 (US$ Million)
13.2.10.6. U.S. Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
13.2.10.7. U.S. Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
13.2.10.8. U.S. Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
13.2.11. Canada
13.2.11.1. Overview
13.2.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
13.2.11.3. Canada Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
13.2.11.4. Canada Market Size and Forecast, By Workflow Stage, 2020 - 2033 (US$ Million)
13.2.11.5. Canada Market Size and Forecast, By Therapy Type, 2020 - 2033 (US$ Million)
13.2.11.6. Canada Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
13.2.11.7. Canada Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
13.2.11.8. Canada Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
13.3. Europe
13.3.1. Overview
13.3.2. Cell and Gene Therapy Thawing Equipment Key Manufacturers in Europe
13.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
13.3.4. Europe Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
13.3.5. Europe Market Size and Forecast, By Workflow Stage, 2020 - 2033 (US$ Million)
13.3.6. Europe Market Size and Forecast, By Therapy Type, 2020 - 2033 (US$ Million)
13.3.7. Europe Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
13.3.8. Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
13.3.9. Europe Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
13.3.10. Germany
13.3.10.1. Overview
13.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
13.3.10.3. Germany Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
13.3.10.4. Germany Market Size and Forecast, By Workflow Stage, 2020 - 2033 (US$ Million)
13.3.10.5. Germany Market Size and Forecast, By Therapy Type, 2020 - 2033 (US$ Million)
13.3.10.6. Germany Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
13.3.10.7. Germany Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
13.3.10.8. Germany Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
13.3.11. UK
13.3.11.1. Overview
13.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
13.3.11.3. UK Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
13.3.11.4. UK Market Size and Forecast, By Workflow Stage, 2020 - 2033 (US$ Million)
13.3.11.5. UK Market Size and Forecast, By Therapy Type, 2020 - 2033 (US$ Million)
13.3.11.6. UK Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
13.3.11.7. UK Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
13.3.11.8. UK Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
13.3.12. France
13.3.12.1. Overview
13.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
13.3.12.3. France Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
13.3.12.4. France Market Size and Forecast, By Workflow Stage, 2020 - 2033 (US$ Million)
13.3.12.5. France Market Size and Forecast, By Therapy Type, 2020 - 2033 (US$ Million)
13.3.12.6. France Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
13.3.12.7. France Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
13.3.12.8. France Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
13.3.13. Italy
13.3.13.1. Overview
13.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
13.3.13.3. Italy Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
13.3.13.4. Italy Market Size and Forecast, By Workflow Stage, 2020 - 2033 (US$ Million)
13.3.13.5. Italy Market Size and Forecast, By Therapy Type, 2020 - 2033 (US$ Million)
13.3.13.6. Italy Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
13.3.13.7. Italy Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
13.3.13.8. Italy Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
13.3.14. Spain
13.3.14.1. Overview
13.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
13.3.14.3. Spain Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
13.3.14.4. Spain Market Size and Forecast, By Workflow Stage, 2020 - 2033 (US$ Million)
13.3.14.5. Spain Market Size and Forecast, By Therapy Type, 2020 - 2033 (US$ Million)
13.3.14.6. Spain Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
13.3.14.7. Spain Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
13.3.14.8. Spain Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
13.3.15. The Netherlands
13.3.15.1. Overview
13.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
13.3.15.3. The Netherlands Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
13.3.15.4. The Netherlands Market Size and Forecast, By Workflow Stage, 2020 - 2033 (US$ Million)
13.3.15.5. The Netherlands Market Size and Forecast, By Therapy Type, 2020 - 2033 (US$ Million)
13.3.15.6. The Netherlands Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
13.3.15.7. The Netherlands Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
13.3.15.8. The Netherlands Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
13.3.16. Sweden
13.3.16.1. Overview
13.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
13.3.16.3. Sweden Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
13.3.16.4. Sweden Market Size and Forecast, By Workflow Stage, 2020 - 2033 (US$ Million)
13.3.16.5. Sweden Market Size and Forecast, By Therapy Type, 2020 - 2033 (US$ Million)
13.3.16.6. Sweden Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
13.3.16.7. Sweden Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
13.3.16.8. Sweden Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
13.3.17. Russia
13.3.17.1. Overview
13.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
13.3.17.3. Russia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
13.3.17.4. Russia Market Size and Forecast, By Workflow Stage, 2020 - 2033 (US$ Million)
13.3.17.5. Russia Market Size and Forecast, By Therapy Type, 2020 - 2033 (US$ Million)
13.3.17.6. Russia Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
13.3.17.7. Russia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
13.3.17.8. Russia Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
13.3.18. Poland
13.3.18.1. Overview
13.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
13.3.18.3. Poland Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
13.3.18.4. Poland Market Size and Forecast, By Workflow Stage, 2020 - 2033 (US$ Million)
13.3.18.5. Poland Market Size and Forecast, By Therapy Type, 2020 - 2033 (US$ Million)
13.3.18.6. Poland Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
13.3.18.7. Poland Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
13.3.18.8. Poland Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
13.3.19. Denmark
13.3.19.1. Overview
13.3.19.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
13.3.19.3. Denmark Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
13.3.19.4. Denmark Market Size and Forecast, By Workflow Stage, 2020 - 2033 (US$ Million)
13.3.19.5. Denmark Market Size and Forecast, By Therapy Type, 2020 - 2033 (US$ Million)
13.3.19.6. Denmark Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
13.3.19.7. Denmark Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
13.3.19.8. Denmark Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
13.3.20. Rest of Europe
13.3.20.1. Overview
13.3.20.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
13.3.20.3. Rest of the Europe Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
13.3.20.4. Rest of the Europe Market Size and Forecast, By Workflow Stage, 2020 - 2033 (US$ Million)
13.3.20.5. Rest of the Europe Market Size and Forecast, By Therapy Type, 2020 - 2033 (US$ Million)
13.3.20.6. Rest of the Europe Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
13.3.20.7. Rest of the Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
13.3.20.8. Rest of the Europe Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
13.4. Asia Pacific (APAC)
13.4.1. Overview
13.4.2. Cell and Gene Therapy Thawing Equipment Key Manufacturers in Asia Pacific
13.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
13.4.4. APAC Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
13.4.5. APAC Market Size and Forecast, By Workflow Stage, 2020 - 2033 (US$ Million)
13.4.6. APAC Market Size and Forecast, By Therapy Type, 2020 - 2033 (US$ Million)
13.4.7. APAC Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
13.4.8. APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
13.4.9. APAC Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
13.4.10. China
13.4.10.1. Overview
13.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
13.4.10.3. China Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
13.4.10.4. China Market Size and Forecast, By Workflow Stage, 2020 - 2033 (US$ Million)
13.4.10.5. China Market Size and Forecast, By Therapy Type, 2020 - 2033 (US$ Million)
13.4.10.6. China Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
13.4.10.7. China Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
13.4.10.8. China Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
13.4.11. India
13.4.11.1. Overview
13.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
13.4.11.3. India Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
13.4.11.4. India Market Size and Forecast, By Workflow Stage, 2020 - 2033 (US$ Million)
13.4.11.5. India Market Size and Forecast, By Therapy Type, 2020 - 2033 (US$ Million)
13.4.11.6. India Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
13.4.11.7. India Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
13.4.11.8. India Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
13.4.12. Japan
13.4.12.1. Overview
13.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
13.4.12.3. Japan Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
13.4.12.4. Japan Market Size and Forecast, By Workflow Stage, 2020 - 2033 (US$ Million)
13.4.12.5. Japan Market Size and Forecast, By Therapy Type, 2020 - 2033 (US$ Million)
13.4.12.6. Japan Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
13.4.12.7. Japan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
13.4.12.8. Japan Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
13.4.13. South Korea
13.4.13.1. Overview
13.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
13.4.13.3. South Korea Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
13.4.13.4. South Korea Market Size and Forecast, By Workflow Stage, 2020 - 2033 (US$ Million)
13.4.13.5. South Korea Market Size and Forecast, By Therapy Type, 2020 - 2033 (US$ Million)
13.4.13.6. South Korea Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
13.4.13.7. South Korea Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
13.4.13.8. South Korea Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
13.4.14. Australia
13.4.14.1. Overview
13.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
13.4.14.3. Australia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
13.4.14.4. Australia Market Size and Forecast, By Workflow Stage, 2020 - 2033 (US$ Million)
13.4.14.5. Australia Market Size and Forecast, By Therapy Type, 2020 - 2033 (US$ Million)
13.4.14.6. Australia Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
13.4.14.7. Australia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
13.4.14.8. Australia Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
13.4.15. Indonesia
13.4.15.1. Overview
13.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
13.4.15.3. Indonesia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
13.4.15.4. Indonesia Market Size and Forecast, By Workflow Stage, 2020 - 2033 (US$ Million)
13.4.15.5. Indonesia Market Size and Forecast, By Therapy Type, 2020 - 2033 (US$ Million)
13.4.15.6. Indonesia Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
13.4.15.7. Indonesia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
13.4.15.8. Indonesia Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
13.4.16. Thailand
13.4.16.1. Overview
13.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
13.4.16.3. Thailand Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
13.4.16.4. Thailand Market Size and Forecast, By Workflow Stage, 2020 - 2033 (US$ Million)
13.4.16.5. Thailand Market Size and Forecast, By Therapy Type, 2020 - 2033 (US$ Million)
13.4.16.6. Thailand Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
13.4.16.7. Thailand Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
13.4.16.8. Thailand Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
13.4.17. Philippines
13.4.17.1. Overview
13.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
13.4.17.3. Philippines Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
13.4.17.4. Philippines Market Size and Forecast, By Workflow Stage, 2020 - 2033 (US$ Million)
13.4.17.5. Philippines Market Size and Forecast, By Therapy Type, 2020 - 2033 (US$ Million)
13.4.17.6. Philippines Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
13.4.17.7. Philippines Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
13.4.17.8. Philippines Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
13.4.18. Taiwan
13.4.18.1. Overview
13.4.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
13.4.18.3. Taiwan Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
13.4.18.4. Taiwan Market Size and Forecast, By Workflow Stage, 2020 - 2033 (US$ Million)
13.4.18.5. Taiwan Market Size and Forecast, By Therapy Type, 2020 - 2033 (US$ Million)
13.4.18.6. Taiwan Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
13.4.18.7. Taiwan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
13.4.18.8. Taiwan Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
13.4.19. Vietnam
13.4.19.1. Overview
13.4.19.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
13.4.19.3. Vietnam Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
13.4.19.4. Vietnam Market Size and Forecast, By Workflow Stage, 2020 - 2033 (US$ Million)
13.4.19.5. Vietnam Market Size and Forecast, By Therapy Type, 2020 - 2033 (US$ Million)
13.4.19.6. Vietnam Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
13.4.19.7. Vietnam Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
13.4.19.8. Vietnam Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
13.4.20. Rest of APAC
13.4.20.1. Overview
13.4.20.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
13.4.20.3. Rest of APAC Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
13.4.20.4. Rest of APAC Market Size and Forecast, By Workflow Stage, 2020 - 2033 (US$ Million)
13.4.20.5. Rest of APAC Market Size and Forecast, By Therapy Type, 2020 - 2033 (US$ Million)
13.4.20.6. Rest of APAC Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
13.4.20.7. Rest of APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
13.5. Latin America (LATAM)
13.5.1. Overview
13.5.2. Cell and Gene Therapy Thawing Equipment Key Manufacturers in Latin America
13.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
13.5.4. LATAM Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
13.5.5. LATAM Market Size and Forecast, By Workflow Stage, 2020 - 2033 (US$ Million)
13.5.6. LATAM Market Size and Forecast, By Therapy Type, 2020 - 2033 (US$ Million)
13.5.7. LATAM Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
13.5.8. LATAM Size and Forecast, By End User, 2020 - 2033 (US$ Million)
13.5.9. LATAM Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
13.5.10. Brazil
13.5.10.1. Overview
13.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
13.5.10.3. Brazil Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
13.5.10.4. Brazil Market Size and Forecast, By Workflow Stage, 2020 - 2033 (US$ Million)
13.5.10.5. Brazil Market Size and Forecast, By Therapy Type, 2020 - 2033 (US$ Million)
13.5.10.6. Brazil Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
13.5.10.7. Brazil Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
13.5.10.8. Brazil Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
13.5.11. Mexico
13.5.11.1. Overview
13.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
13.5.11.3. Mexico Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
13.5.11.4. Mexico Market Size and Forecast, By Workflow Stage, 2020 - 2033 (US$ Million)
13.5.11.5. Mexico Market Size and Forecast, By Therapy Type, 2020 - 2033 (US$ Million)
13.5.11.6. Mexico Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
13.5.11.7. Mexico Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
13.5.11.8. Mexico Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
13.5.12. Argentina
13.5.12.1. Overview
13.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
13.5.12.3. Argentina Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
13.5.12.4. Argentina Market Size and Forecast, By Workflow Stage, 2020 - 2033 (US$ Million)
13.5.12.5. Argentina Market Size and Forecast, By Therapy Type, 2020 - 2033 (US$ Million)
13.5.12.6. Argentina Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
13.5.12.7. Argentina Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
13.5.12.8. Argentina Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
13.5.13. Colombia
13.5.13.1. Overview
13.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
13.5.13.3. Colombia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
13.5.13.4. Colombia Market Size and Forecast, By Workflow Stage, 2020 - 2033 (US$ Million)
13.5.13.5. Colombia Market Size and Forecast, By Therapy Type, 2020 - 2033 (US$ Million)
13.5.13.6. Colombia Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
13.5.13.7. Colombia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
13.5.13.8. Colombia Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
13.5.14. Rest of LATAM
13.5.14.1. Overview
13.5.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
13.5.14.3. Rest of LATAM Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
13.5.14.4. Rest of LATAM Market Size and Forecast, By Workflow Stage, 2020 - 2033 (US$ Million)
13.5.14.5. Rest of LATAM Market Size and Forecast, By Therapy Type, 2020 - 2033 (US$ Million)
13.5.14.6. Rest of LATAM Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
13.5.14.7. Rest of LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
13.5.14.8. Rest of LATAM Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
13.6. Middle East and Africa
13.6.1. Overview
13.6.2. Cell and Gene Therapy Thawing Equipment Key Manufacturers in Middle East and Africa
13.6.3. Middle East and Africa Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
13.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
13.6.5. Middle East and Africa Market Size and Forecast, By Workflow Stage, 2020 - 2033 (US$ Million)
13.6.6. Middle East and Africa Market Size and Forecast, By Therapy Type, 2020 - 2033 (US$ Million)
13.6.7. Middle East and Africa Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
13.6.8. Middle East and Africa Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
13.6.9. Middle East and Africa Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
13.6.10. Saudi Arabia
13.6.10.1. Overview
13.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
13.6.10.3. Saudi Arabia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
13.6.10.4. Saudi Arabia Market Size and Forecast, By Workflow Stage, 2020 - 2033 (US$ Million)
13.6.10.5. Saudi Arabia Market Size and Forecast, By Therapy Type, 2020 - 2033 (US$ Million)
13.6.10.6. Saudi Arabia Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
13.6.10.7. Saudi Arabia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
13.6.10.8. Saudi Arabia Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
13.6.11. United Arab Emirates
13.6.11.1. Overview
13.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
13.6.11.3. United Arab Emirates Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
13.6.11.4. United Arab Emirates Market Size and Forecast, By Workflow Stage, 2020 - 2033 (US$ Million)
13.6.11.5. United Arab Emirates Market Size and Forecast, By Therapy Type, 2020 - 2033 (US$ Million)
13.6.11.6. United Arab Emirates Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
13.6.11.7. United Arab Emirates Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
13.6.11.8. United Arab Emirates Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
13.6.12. Israel
13.6.12.1. Overview
13.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
13.6.12.3. Israel Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
13.6.12.4. Israel Market Size and Forecast, By Workflow Stage, 2020 - 2033 (US$ Million)
13.6.12.5. Israel Market Size and Forecast, By Therapy Type, 2020 - 2033 (US$ Million)
13.6.12.6. Israel Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
13.6.12.7. Israel Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
13.6.12.8. Israel Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
13.6.13. Turkey
13.6.13.1. Overview
13.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
13.6.13.3. Turkey Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
13.6.13.4. Turkey Market Size and Forecast, By Workflow Stage, 2020 - 2033 (US$ Million)
13.6.13.5. Turkey Market Size and Forecast, By Therapy Type, 2020 - 2033 (US$ Million)
13.6.13.6. Turkey Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
13.6.13.7. Turkey Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
13.6.13.8. Turkey Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
13.6.14. Algeria
13.6.14.1. Overview
13.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
13.6.14.3. Algeria Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
13.6.14.4. Algeria Market Size and Forecast, By Workflow Stage, 2020 - 2033 (US$ Million)
13.6.14.5. Algeria Market Size and Forecast, By Therapy Type, 2020 - 2033 (US$ Million)
13.6.14.6. Algeria Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
13.6.14.7. Algeria Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
13.6.14.8. Algeria Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
13.6.15. Egypt
13.6.15.1. Overview
13.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
13.6.15.3. Egypt Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Mill

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Thermo Fisher Scientific
  • Azenta Life Sciences
  • Barkey GmbH & Co. KG
  • Cardinal Health
  • Cytiva
  • BioLife Solutions
  • Sartorius
  • Merck KGaA
  • PHC Holdings Corporation
  • Eppendorf
  • Helmer Scientific
  • B Medical Systems
  • Azenta Life Sciences
  • Cytiva
  • MedCision
  • Haier Biomedical
  • Others

GLOBAL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2020 - 2033

  • Automated Thawing Systems
  • Manual Thawing Devices
  • Water-Free / Dry Thawing Systems
  • Accessories & Consumables

GLOBAL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY WORKFLOW STAGE- MARKET ANALYSIS, 2020 - 2033

  • Research & Preclinical Applications
  • Clinical Use
  • Commercial Manufacturing

GLOBAL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY THERAPY TYPE- MARKET ANALYSIS, 2020 - 2033

  • Cell Therapy
  • Gene Therapy
  • Gene-Modified Cell Therapy

GLOBAL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY MODALITY- MARKET ANALYSIS, 2020 - 2033

  • Benchtop
  • Portable

GLOBAL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY END USER- MARKET ANALYSIS, 2020 - 2033

  • Biopharmaceutical & Biotechnology Companies
  • Contract Development & Manufacturing Organizations (CDMOs)
  • Academic & Research Institutes
  • Hospitals & Clinical Centers
  • Cord Blood and Stem Cell Banks
  • Gene Banks

GLOBAL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL- MARKET ANALYSIS, 2020 - 2033

  • Direct Tender
  • Third Party Distributor

GLOBAL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033

North America

  • U.S.
  • Canada

Europe

  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe

Asia Pacific

  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM

The Middle East and Africa

  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA
Request For Sample
Choose License Type
assit assit
Related Reports

Credibility and Certifications

Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.

ISO Certification ISO 9001:2015
ESOMAR Individual ESOMAR Corporate
GDPR Compliance GDPR Compliance
D-U-N-S Registered D-U-N-S Registered
BBB Accreditation BBB Accreditation
MRS MRS
CONTACT INFORMATION

Email:

inquiry@analystviewmarketinsights.com

U.S. Office

11923 NE Sumner St STE 750924
Portland, Oregon, 97220, USA

Asia Pacific Office

4, Rohan Business Centre, Paud Road,
Kothrud, Pune Maharashtra, 411038, India

QUICK LINKS
RESOURCES
Secure Payment By
PayPal
Visa
MasterCard
American Express
Support Hours

We’re here to assist you around the clock, six days a week.

Monday – Friday: 10:00 AM to 6:00 PM

Saturday: 10:00 AM to 3:00 PM

Sunday: Closed

© Copyright 2026 Analystview Market Insights | All Rights Reserved